A novel nomogram to predict survival of patients with hepatocellular carcinoma after transarterial chemoembolization: a tool for retreatment decision making

BACKGROUND: There is still no standardized policy regarding how to identify patients who are not benefiting from transarterial chemoembolization (TACE). We aimed to establish and validate a nomogram model to predict the survival rate of hepatocellular carcinoma (HCC) patients after TACE. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Li, Chengjun, Zhu, Guoqing, Yang, Junhui, Zhang, Yunjie, Yu, Zhijie, Xia, Jinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929754/
https://www.ncbi.nlm.nih.gov/pubmed/36819596
http://dx.doi.org/10.21037/atm-22-6513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929754/
https://www.ncbi.nlm.nih.gov/pubmed/36819596
http://dx.doi.org/10.21037/atm-22-6513

Ejemplares similares